# FDA Inspection 1117578 - Telix IsoTherapeutics Group, Inc. - February 03, 2020

Source: https://www.keypedia.com/records/fda_inspections/telix-isotherapeutics-group-inc/3bad0e48-0020-4669-bec4-7c1afc264c17
Source feed: FDA_Inspections

> FDA Inspection 1117578 for Telix IsoTherapeutics Group, Inc. on February 03, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1117578
- Company Name: Telix IsoTherapeutics Group, Inc.
- Inspection Date: 2020-02-03
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1277105 - 2025-07-31](https://www.keypedia.com/records/fda_inspections/telix-isotherapeutics-group-inc/00ed8c68-0d69-4e9f-a178-27095a6fa684)
- [FDA Inspection 1277105 - 2025-07-31](https://www.keypedia.com/records/fda_inspections/telix-isotherapeutics-group-inc/c54e9aea-a7b2-4698-9beb-caa779aaf812)
- [FDA Inspection 994402 - 2016-11-30](https://www.keypedia.com/records/fda_inspections/telix-isotherapeutics-group-inc/45a36c60-c823-47e3-a2de-2919206edb0f)

Company: https://www.keypedia.com/companies/telix-isotherapeutics-group-inc/4c1ef15c-5396-4f70-9e46-da410d1485cc

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c